← Contracts
PT
Aquisição de Medicamentos do aparelho geniturinário (AQ2023495)
ID 11261432
· Portal BASE
Price
Base Price
€72,585
.00
Effective Price
€1,565
.00
-97.8%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- 11
Winner
GENERIS - FARMACÊUTICA, S.A.
NIF 508107997
Competition
11 bidders recorded
OVERPHARMA - PRODUTOS MÉDICOS E FARMACÊUTICOS LDA
NIF 505792362
Accord Healthcare, Unipessoal (508622263), Takeda Farmacêuticos Portugal, Lda (502801204), GlaxoSmithKline - Produtos Farmacêuticos, Lda (500139962), Hikma Farmaceutica (Portugal) Lda (502266791), LAB. PFIZER, LDA. (500162166), Zentiva Portugal, Lda.
NIF 503103551
LOGIFARMA - LOGÍSTICA FARMACÊUTICA S.A.
NIF 503934640
MYLAN, LDA.
NIF 502248793
LABORATÓRIOS PFIZER LDA
NIF 500162166
FERRER PORTUGAL S.A.
NIF 500069190
FARMOZ - SOCIEDADE TÉCNICO MEDICINAL S.A.
NIF 501505334
SANDOZ FARMACÊUTICA LDA
NIF 506985261
GENERIS - FARMACÊUTICA, S.A.
NIF 508107997
JABA RECORDATI, SA.
NIF 500492867
DLA FARMACEUTICA SA
NIF 503894427
Dates
- Publication
- 05 Mar 2025
- Celebration
- 20 Feb 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 85 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 05 Mar 2025
- Signing Date
- 20 Feb 2025
- Days Late
- 13
- Rule
- A2/A3 late publication: 13 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
- Base price
- 72585.0
- Threshold
- 75000.0
- Rule
- A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 72585.0
- Total effective price
- 1565.0
- Ratio
- 0.0216
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0216 outside [0.5, 1.5]
Detected 2026-03-06